Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly

Clin Geriatr Med. 1992 Feb;8(1):183-99.


Influenza and pneumococcal vaccines are safe, effective, and cost-effective, but they are not used widely. Organized programs for vaccine delivery can lead to substantial improvements in vaccination rates for the elderly. Adequate reimbursement by Medicare and other third-party payers needs to be supplemented by educational programs to promote influenza and pneumococcal vaccines if the opportunity vaccination presents to improve the health and well-being of elderly persons is to be fully realized.

Publication types

  • Review

MeSH terms

  • Aged
  • Bacterial Vaccines*
  • Health Knowledge, Attitudes, Practice
  • Health Policy*
  • Health Services for the Aged
  • Hospitalization
  • Humans
  • Influenza Vaccines*
  • Influenza, Human / prevention & control
  • Pneumococcal Infections / prevention & control
  • Streptococcus pneumoniae / immunology*
  • United States
  • Vaccination* / economics
  • Vaccination* / psychology


  • Bacterial Vaccines
  • Influenza Vaccines